Vitamin D Poisoning; Hypercalcemia in a Case with Richter Transformation
Vitamine D Poisoning; Hipercalcemia
Keywords:
Vitamin D poisoning; emergency department; hypercalsemiaAbstract
In addition to modern medicine, the search for complementary and alternative medicine has been present for malignancy patients in every period. Confusion, polyuria, polydipsia, anorexia, vomiting, and muscle weakness are symptoms of acute poisoning and are related to hypercalcemia.
In our case, a 52-year-old male patient applied to the Emergency Department(ED) with abdominal pain and weakness for two days. In this article, we wanted to present a case with vitamin D poisoning that occurs after the phytotherapy in a patient who developed chronic lymphocytic leukemia (CLL) to Richter transformation. In some patients, especially at ED, taking a high dose of vitamin D history can be challenging. In patients with hypercalcemia, a careful history should be taken, and it should be questioned as "Vitamin D use" rather than "Drug use" since families do not accept the vitamins as drugs.
References
References
Asonitis N, Angelousi A, Zafeiris C et al. Diagnosis, Pathophysiology and Management of Hypercalcemia in Malignancy: A Review of the Literature Hypercalcemia of Malignancy. Horm Metab Res 2019; 51: 770–778.
Paydaş S, Kronik Lenfositik Lösemi (KLL), Saçlı Hücreli Lösemi (SHL), Mantle Hücreli Lenfoma (MHL). http://www.thd.org.tr/thdData/userfiles/file/kronik_lenfositik.pdf.
Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Otten JJ, Hellwig JP, Meyers LD (Eds), The National Academies Press, Washington, DC 2006. pp.530-541. Modified with permission from the National Academies Press, Copyright © 2006, National Academy of Sciences.
Michael F. Holick, Neil C. Binkley, Bischoff-Ferrari et al. Clinical Practice Guideline: Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society Clinical Practice Guideline. JCEM 2011; 96: 1911-1930.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-898.
Lumachi F, Brunello A, Roma A et al. Cancer-induced hypercalcemia. Anticancer Res 2009; 29: 1551–1555.
Inzucchi SE. Understanding hypercalcemia. Its metabolic basis, signs, and symptoms. Postgrad Med 2004; 115: 69–70 73–66.
Clines GA. Mechanisms and treatment of hypercalcemia of malignancy. Curr Opin Endocrinol Diabetes Obesity 2011; 18: 339–346.
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
